Teva Returns To Growth For First Time In Six Years

The company also announced plans to divest its active pharmaceutical ingredients (API) business as part of its ‘Pivot to Growth’ strategy.

Teva's US headquarters in Parsippany, NJ • Source: Shutterstock

More from Strategy

More from Business